WithdrawnNCT04807829
Adjunctive CB1 Agonist Nabilone in Inpatients With Active Suicide prevention
Medication studyAges 18–65United States
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- HoustonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: April 2021
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- The University of Texas Health Science Center, Houston
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT04807829
- Official title
Show the full official title
A Randomized-Controlled Trial With the Adjunctive CB1 Agonist Nabilone in Inpatients With Active Suicidal Ideation
Recruitment & locations
WithdrawnHouston
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is The University of Texas Health Science Center, Houston, a university.
Does this study involve medication?
Yes. The study involves medication, including Nabilone and Placebo.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
Want to find a study that may fit you better?
Explore HopeStage studies by mental health topic and refine the results to suit your situation.
Find a study that may fit me